Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannex is a medical cannabis and cannabinoid products company operating through Cannex Pharma Co., Ltd. and Cannex Lab Co., Ltd. in Thailand. The company describes itself as a vertically integrated platform spanning cultivation, extraction, refinement, quality control, and commercial supply of pharmaceutical-grade cannabis-derived formulations, including full-spectrum oils and THC-free CBD isolate. Its capabilities include chromatography-based separation, LC-MS/MS analytics, and development of tailored cannabinoid profiles for pharmacies, healthcare providers, wellness brands, and distributors. Cannex emphasizes compliance with GACP, Thai GAP, export licensing, and PIC/S GMDP or EU-GMP-aligned quality systems, with commercialization focused on regulated international markets such as the UK, Germany, Australia, and Japan. The business appears to be centered on cannabinoid ingredient supply and finished-product formulation rather than a traditional drug-development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannex.